Massimo Corradi - Concepedia

Author

Massimo Corradi

Also Known As

Corradi, Corradi, M., Corradi, Massimo, M CORRADI, M Corradi, M. Corradi, M. G. Corradi, M., Corradi, M.G Corradi, M.G. Corradi

255

Publications

10.8K

Citations

H-Index

138

Concepts

All Affiliations

University of Parma University of Brescia University of Padua Istituto Nazionale per l'Assicurazione Contro gli Infortuni sul Lavoro University of Verona

About

Massimo Corradi is an author at University of Parma specializing in medicine, allergy, and asthma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	47	5.1K
2	Engineering	6	6	221
3	Natural Sciences	4	4	131
4	Health Sciences	2	2	152
5	Education	1	1	16

Massimo Corradi

111

Publications

9.6K

Citations

H-Index

Page 1

	Year	Citations
A European Respiratory Society technical standard: exhaled biomarkers in lung disease Ildikó Horváth, Peter J. Barnes, Stelios Loukides, European Respiratory Journal	2017	611
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial Alberto Papi, Jørgen Vestbo, Leonardo M. Fabbri, The Lancet Advanced Lung DiseaseRespiratory TherapyPulmonary PharmacologyParallel GroupPulmonary Medicine	2018	611
Increased 8-Isoprostane, a Marker of Oxidative Stress, in Exhaled Condensate of Asthma Patients Paolo Montuschi, Massimo Corradi, Giovanni Ciabattoni, American Journal of Respiratory and Critical Care Medicine	1999	552
Exhaled 8-Isoprostane as an <i>In Vivo</i> Biomarker of Lung Oxidative Stress in Patients with COPD and Healthy Smokers Paolo Montuschi, John V. Collins, Giovanni Ciabattoni, American Journal of Respiratory and Critical Care Medicine AsthmaAllergyLung InflammationMedicinePhysiology	2000	547
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial Jørgen Vestbo, Alberto Papi, Massimo Corradi, The Lancet Pulmonary CarePulmonary PharmacologyParallel GroupPharmacotherapyMedicine	2017	433
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial Dave Singh, Alberto Papi, Massimo Corradi, The Lancet Advanced Lung DiseasePulmonary PharmacologyParallel GroupPulmonary MedicineLong-acting β2-Agonist Therapy	2016	412
Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study Diana Poli, Paolo Carbognani, Massimo Corradi, Respiratory Research	2005	409
Determination of aldehydes in exhaled breath of patients with lung cancer by means of on-fiber-derivatisation SPME–GC/MS Diana Poli, Matteo Goldoni, Massimo Corradi, Journal of Chromatography B Respiratory ToxicologyMedicineBioanalysisPathologyOn-fiber-derivatisation Spme–gc/ms	2010	297
Aldehydes in Exhaled Breath Condensate of Patients with Chronic Obstructive Pulmonary Disease Massimo Corradi, Israel Rubinstein, Roberta Andreoli, American Journal of Respiratory and Critical Care Medicine AsthmaAldehyde LevelsLung InflammationOxidative StressRespiratory Toxicology	2003	241
Increased Nitrosothiols in Exhaled Breath Condensate in Inflammatory Airway Diseases Massimo Corradi, Paolo Montuschi, Louise Donnelly, American Journal of Respiratory and Critical Care Medicine	2001	210

Page 1